Trial NCT02954406

View at ClinicalTrials.gov 
Org. Study IDs: C34005
Secondary IDs: 2016-001426-34 U1111-1188-0891

Last trial update was posted on 2022-02-18

MeSH Interventions

Bendamustine Hydrochloride Gemcitabine Ibrutinib Lenalidomide Rituximab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin

Other Conditions


Stopping Reasons

Business decision, insufficient enrollment, no safety or efficacy concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID